» Articles » PMID: 38188344

Regional Moderate Hyperthermia for Mild-to-moderate COVID-19 (TherMoCoV Study): a Randomized Controlled Trial

References
1.
Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

2.
Mancilla-Galindo J, Vera-Zertuche J, Navarro-Cruz A, Segura-Badilla O, Reyes-Velazquez G, Tepepa-Lopez F . Development and validation of the patient history COVID-19 (PH-Covid19) scoring system: a multivariable prediction model of death in Mexican patients with COVID-19. Epidemiol Infect. 2020; 148:e286. PMC: 7729170. DOI: 10.1017/S0950268820002903. View

3.
Liikkanen L, Laukkanen J . Sauna bathing frequency in Finland and the impact of COVID-19. Complement Ther Med. 2020; 56:102594. DOI: 10.1016/j.ctim.2020.102594. View

4.
Agarwal A, Hunt B, Stegemann M, Rochwerg B, Lamontagne F, Ac Siemieniuk R . A living WHO guideline on drugs for covid-19. BMJ. 2020; 370:m3379. DOI: 10.1136/bmj.m3379. View

5.
Wang Y, Fan G, Horby P, Hayden F, Li Q, Wu Q . Comparative Outcomes of Adults Hospitalized With Seasonal Influenza A or B Virus Infection: Application of the 7-Category Ordinal Scale. Open Forum Infect Dis. 2019; 6(3):ofz053. PMC: 6419989. DOI: 10.1093/ofid/ofz053. View